Antitumor effects of cardiovascular drugs
Cardiovascular disease (CVD) and oncological diseases are the leading causes of death in the world. The widespread use of cardiovascular drugs makes it important to study their potential antitumor and carcinogenic effects. The article provides information on the most relevant clinical and experiment...
Main Authors: | I. I. Shaposhnik, V. V. Genkel |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5812 |
Similar Items
-
Antiplatelet drug resistance in patients with coronary heart disease
by: V. A. Sulimov, et al.
Published: (2012-12-01) -
RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: D. H. Aynetdinova, et al.
Published: (2015-12-01) -
ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE
by: I. S. Yavelov
Published: (2009-03-01) -
FEATURES OF PLATELET HEMOSTASIS IN PATIENTS WITH VARIOUS SENSITIVITY TO ANTIPLATELET THERAPY IN STABLE ANGINA PECTORIS AFTER PLANNED PERCUTANEOUS CORONARY INTERVENTION
by: Pronko T. P., et al.
Published: (2017-12-01) -
Experimental study of systemic hemostatic effects of fibrin monomer in inhibition of platelet aggregation function
by: V. M. Vdovin, et al.
Published: (2020-04-01)